Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults
without Diabetes or Prediabetes New-User, Active-Comparator Analysis
using the
National COVID Cohort Collaborative (N3C) Database
